"/> Novus Biologicals™ Peptide bloquant d’anticorps NA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps NAT11

Réf. : BL-RE-048568Réf. fabricant : 18240306 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
79829
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77095. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the carboxy terminus of human NAT11.

Points forts

Source

Synthetic

(Accession #: NP_079047) The NAT11 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-048568
Réf. fabricant18240306
Gene ID (Entrez)79829
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77095. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneEC 2.3.1.-, FLJ13848, N(alpha)-acetyltransferase 40, NatD catalytic subunit, homolog (S. cerevisiae), N-acetyltransferase 11, N-acetyltransferase 11 (GCN5-related, putative), N-alpha-acetyltransferase 40, NatD catalytic subunit, NAT11, PATT1
Symbole de gène(s)NAA40
Type de produitNAT11
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the carboxy terminus of human NAT11
Une question, une configuration particulière ?
Contactez-nous pour un devis.